Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
10/25/2001 | US20010034019 Chimeric HCV/GBV-B viruses |
10/25/2001 | US20010034018 Contacting a sample with an antibody which binds to SVI (Sentinel virus 1) or a protein and the antibody does not bind TTV strains SANBAN and TUS01 or protiens and detecting the complexes of antibody and SVI virus or protein |
10/25/2001 | US20010033972 Comprises nonaqueous electrolytic solution and current collector coated with active material and immersed in electrolytic solution; lightweight, useful for electric hybrid vehicles |
10/25/2001 | US20010033840 Methods for inducing T cell tolerance to a tissue or organ graft |
10/25/2001 | DE10020125A1 Agent for stimulating bone regrowth, useful as insert after surgery for bone cancer, comprises single sequence expressing a fusion of growth factor and protease inhibitor |
10/25/2001 | DE10020073A1 New human platelet-activating factor (PAF) receptor-3 gene, useful for diagnosis and treatment of PAF-related diseases |
10/25/2001 | DE10019120A1 New human platelet-activating factor (PAF) receptor-2 gene, useful for diagnosis and treatment of PAF-related diseases |
10/25/2001 | DE10007792A1 Differential diagnosis of autoantibodies against thyroid stimulating hormone receptor in patients sample, useful to detect different thyroid autoimmune diseases including Grave's disease |
10/25/2001 | CA2798625A1 Novel methods of constructing libraries of genetic packages that collectively display the members of a diverse family of peptides, polypeptides or proteins |
10/25/2001 | CA2747325A1 Albumin fusion proteins |
10/25/2001 | CA2407064A1 Screening assay methods and systems using target pooling |
10/25/2001 | CA2406972A1 Cross-linked collagen matrices and methods for their preparation |
10/25/2001 | CA2406955A1 Sheep lice, bovicola ovis, allergen treatment |
10/25/2001 | CA2406590A1 Agent for postoperative use after the removal of bone tumours |
10/25/2001 | CA2406481A1 Trp8, a transient receptor potential channel expressed in taste receptor cells |
10/25/2001 | CA2406472A1 Javelinization of protein antigens to heat shock proteins |
10/25/2001 | CA2406378A1 Targeted vaccine delivery systems |
10/25/2001 | CA2406245A1 Il-174 uses, compositions and methods |
10/25/2001 | CA2406213A1 Compositions and methods for the therapy and diagnosis of breast cancer |
10/25/2001 | CA2406195A1 Lipid binding protein 4 |
10/25/2001 | CA2406192A1 Therapeutic compounds and methods for formulating v3, a versican isoform |
10/25/2001 | CA2406180A1 Viruses comprising mutant ion channel protein |
10/25/2001 | CA2406126A1 Humar emr2, a g-protein coupled receptor from the egf-tm7 family |
10/25/2001 | CA2406121A1 Novel nucleic acids and polypeptides |
10/25/2001 | CA2406087A1 New lipid binding protein 2 |
10/25/2001 | CA2406066A1 Lipid binding protein 3 |
10/25/2001 | CA2406039A1 Materials and methods relating to lipid metabolism |
10/25/2001 | CA2405946A1 Methods and compositions for the treatment of fibrotic conditions and impaired lung function and to enhance lymphocyte production |
10/25/2001 | CA2405781A1 Secreted proteins |
10/25/2001 | CA2405753A1 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
10/25/2001 | CA2405709A1 Albumin fusion proteins |
10/25/2001 | CA2405701A1 Albumin fusion proteins |
10/25/2001 | CA2405563A1 Albumin fusion proteins |
10/25/2001 | CA2405557A1 Albumin fusion proteins |
10/25/2001 | CA2405550A1 Albumin fusion proteins |
10/25/2001 | CA2405525A1 Albumin fusion proteins |
10/25/2001 | CA2405451A1 Molecules associated with human reproduction |
10/25/2001 | CA2405247A1 Tuberculosis antigens and methods of use thereof |
10/25/2001 | CA2405078A1 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease |
10/25/2001 | CA2405033A1 Electrophoresis separation and treatment of samples |
10/25/2001 | CA2404129A1 Codon optimisation for expression in retrovirus packaging cells |
10/25/2001 | CA2404127A1 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor |
10/25/2001 | CA2403547A1 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
10/25/2001 | CA2403508A1 Extracellular matrix polynucleotides, polypeptides, and antibodies |
10/25/2001 | CA2370572A1 Kv10.1, a novel voltage-gated potassium channel from human brain |
10/24/2001 | EP1148339A2 Immunoassay for LSD and 2-Oxo-3-Hydroxy-LSD |
10/24/2001 | EP1148143A2 Cytochrome p450 monooxygenase and NADPH cytochrome p450 oxidoreductase genes and proteins related to the omega hydroxylase complex of Candida tropicalis and methods relating thereto |
10/24/2001 | EP1148138A2 Cytochrome P450 monooxygenase and NADPH cytochrome P450 oxidoreductase genes and proteins related to the omega hydroxylase complex of Candida tropicalis and methods thereto |
10/24/2001 | EP1148137A2 Cytochrome P450 monooxygenase and NADPH cytochrome P450 oxidoreductase genes and proteins related to the omega hydroxylase complex of Candida tropicalis and methods relating thereto |
10/24/2001 | EP1148136A2 Cytochrome P450 monooxygenase and NADPH cytochrome P450 oxidoreductase genes and proteins related to the omega hydroxylase complex of Candida tropicalis and methods relating thereto |
10/24/2001 | EP1148135A2 Cytochrome P450 monooxygenase and NADPH cytochrome P450 oxidoreductase genes and proteins related to the omega hydroxylase complex of Candida tropicalis and methods relating thereto |
10/24/2001 | EP1148134A2 Cytochrome P450 monooxygenase and NADPH cytochrome P450 oxidoreductase genes and proteins related to the omega hydroxylase complex of Candida tropicalis and methods relating thereto |
10/24/2001 | EP1148133A2 Cytochrome P450 monooxygenase and NADPH cytochrome P450 oxidoreductase genes and proteins related to the omega hydroxylase complex of Candida tropicalis and methods relating thereto |
10/24/2001 | EP1148132A2 Cytochrome P450 monooxygenase and NADPH cytochrome P450 oxidoreductase genes and proteins related to the omega hydroxylase complex of Candida tropicalis and methods relating thereto |
10/24/2001 | EP1148131A2 Cytochrome P450 monooxygenase and NADPH cytochrome P450 oxidoreductase genes and proteins related to the omega hydroxylase complex of Candida tropicalis and methods relating thereto |
10/24/2001 | EP1148130A2 Cytochrome P450 monooxygenase and NADPH cytochrome P450 oxidoreductase genes and proteins related to the omega hydroxylase complex of candida tropicalis and methods relating thereto |
10/24/2001 | EP1148129A1 Betacellulin modification |
10/24/2001 | EP1148128A1 Gene locus involved in regulating hair pigmentation, vestibular function and fertility |
10/24/2001 | EP1148127A2 Human G-protein chemokine receptor HDGNR10 (CCR5 receptor). Its uses |
10/24/2001 | EP1148126A2 Human G-protein chemokine receptor HDGNR10 (CCR5 receptor) |
10/24/2001 | EP1148125A1 Human nucleoprotein having www domain and polynucleotide encoding the same |
10/24/2001 | EP1148122A1 PROCESS FOR PRODUCING HMG-CoA REDUCTASE INHIBITOR |
10/24/2001 | EP1148066A1 Use of CD34 or a polypeptide derived therefrom as cell-surface marker in gene-transfer |
10/24/2001 | EP1148065A1 Fusion proteins comprising two soluble gp130 molecules |
10/24/2001 | EP1148064A1 Lactobacillus johnsonii bacteriocin, active against Helicobacter pylori |
10/24/2001 | EP1148063A1 Composition containing hemostatic activ vWF and process for its preparation |
10/24/2001 | EP1148050A1 Retroviral protease inhibitors |
10/24/2001 | EP1147776A2 Use of botulinum toxin type B for the manufacture of a medicament for the treatment of muscle spasms |
10/24/2001 | EP1147775A2 Use of botulinum toxin type B for the manufacture of a medicament for reducing pain associated with a muscle disorder |
10/24/2001 | EP1147415A1 Method and kit for extracting prion protein |
10/24/2001 | EP1147413A2 Growth differentiation factor inhibitors and uses therefor |
10/24/2001 | EP1147227A1 Lipophilic quenching of viral inactivating agents |
10/24/2001 | EP1147213A2 Novel rgs-containing molecules and uses thereof |
10/24/2001 | EP1147212A1 T helper cell epitopes |
10/24/2001 | EP1147201A2 Metalloproteinase-disintegrin family members: svph dnas and polypeptides |
10/24/2001 | EP1147197A2 Schizochytrium pks genes |
10/24/2001 | EP1147195A1 Candida albicans srb-7 |
10/24/2001 | EP1147194A1 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
10/24/2001 | EP1147193A1 Platelet-derived growth factor/vascular endothelial growth factor-like growth factor h, and uses thereof |
10/24/2001 | EP1147192A1 Human nogo-c polynucleotide and polypeptide and their uses |
10/24/2001 | EP1147191A1 Transcriptional regulation of the human beta3-adrenergic receptor gene |
10/24/2001 | EP1147190A1 Her-2/neu fusion proteins |
10/24/2001 | EP1147187A2 Endogenetic nucleic fragment associated with an autoimmune disease, marking method and reagent |
10/24/2001 | EP1147185A2 Mammal, method for producing same and its use |
10/24/2001 | EP1147184A1 Controlled expression of heterologous proteins in the mammary gland of a transgenic animal |
10/24/2001 | EP1147183A1 Nucleic acid and amino acid sequences |
10/24/2001 | EP1147177A2 Control of virus infection using replication associated proteins, compositions and methods of use |
10/24/2001 | EP1147136A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF |
10/24/2001 | EP1147135A1 Novel g protein-coupled receptor |
10/24/2001 | EP1147134A1 Novel potassium channels and genes encoding these potassium channels |
10/24/2001 | EP1147133A2 Pth functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules |
10/24/2001 | EP1147132A2 Antiviral peptides |
10/24/2001 | EP1147131A1 Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin |
10/24/2001 | EP1147130A1 Alpha-conotoxin peptides |
10/24/2001 | EP1147128A1 Binding molecules for human factor viii and factor viii-like proteins |
10/24/2001 | EP1147126A2 Co-factors for trophic factors, and methods of use thereof |
10/24/2001 | EP1147125A1 Brain-derived alkali-soluble immunoregulatory composition |
10/24/2001 | EP1147123A2 Novel odorant receptors in drosophila |
10/24/2001 | EP1147122A2 Methods for altering organ mass, controlling fertility and enhancing asexual reproduction in plants |
10/24/2001 | EP1146909A1 Method of treating cancer by restoration of pp32 function |